TMC Implant Fixation System
Treace Medical Concepts, Inc. · Decision date Sep 15, 2026
What did the FDA decide?
Treace Medical Concepts, Inc. received FDA clearance for the TMC Implant Fixation System under K262963, a Special 510(k) premarket notification. The September 15, 2026 decision letter records a substantially equivalent determination, which permits marketing under general controls rather than constituting PMA approval. The submission was dated August 24, 2026 and received August 25, 2026, with the summary dated September 9, 2026. The device is a Class II bone fixation system under 21 CFR 888.3030, with primary product code HRS and subsequent codes JDR and HWC.
The system comprises straight, L-shaped, H-shaped, anatomically curved and intramedullary plates, cannulated and non-cannulated compression implants, and associated instruments, plus 2.5, 2.7, 3.0 and 3.3 mm locking and non-locking screws in 10–36 mm lengths, all of Ti6Al4V-ELI titanium alloy and gamma-irradiated sterile. The primary predicate is the same-named system cleared as K251135 on August 21, 2025; additional predicates are the Wright PROSTEP TBI System (K190970). The summary states the changes do not affect reprocessing, biocompatibility or sterility, and reports mechanical construct testing to ASTM F382 and F543. The specific changed item is not identified in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262963
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Treace Medical Concepts, Inc.
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- Treace Medical Concepts, Inc.
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K262963 received
Application receipt date recorded by FDA.
K262963 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| ARTHREX, INC. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Skeletal Dynamics, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
ANTHEM Fracture SystemK262779 | GLOBUS MEDICAL, INC. | 510(k) clearance | Oct 23, 2026 | FDA |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Treace Medical Concepts, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ponte Vedra, FL
Sources and methodology
- Original FDA record: K262963
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


